Severity in irritable bowel syndrome: a Rome Foundation Working Team report. - Wikidata - wikimedia - TriplyDB

Severity in irritable bowel syndrome: a Rome Foundation Working Team report.

Severity in irritable bowel syndrome: a Rome Foundation Working Team report.

http://www.wikidata.org/entity/Q37900126

about

Novel perspectives on therapeutic modulation of the gut microbiota New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists Changes in the modulation of spinal pain processing are related to severity in irritable bowel syndrome.Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine.Stress and sleep quality in doctors working on-call shifts are associated with functional gastrointestinal disorders.Qualitative development of a patient-reported outcome symptom measure in diarrhea-predominant irritable bowel syndrome.I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life.Traditional Chinese medicine (Shun-Qi-Tong-Xie Granule) for irritable bowel syndrome: study protocol for a randomised controlled trial Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome.The Danish Symptom Cohort: Questionnaire and Feasibility in the Nationwide Study on Symptom Experience and Healthcare-Seeking among 100 000 Individuals The microbiota-gut-brain axis in functional gastrointestinal disorders.Irritable bowel syndrome: a clinical review Multiple perspectives on symptom interpretation in primary care research.Functional urological disorders: a sensitized defence response in the bladder-gut-brain axis.On-demand treatment with alverine citrate/simeticone compared with standard treatments for irritable bowel syndrome: results of a randomised pragmatic study Latent structure of irritable bowel syndrome symptom severity.The severity of irritable bowel syndrome or the presence of fibromyalgia influencing the perception of visceral and somatic stimuli Intestinal symptoms and psychological factors jointly affect quality of life of patients with irritable bowel syndrome with diarrhea Risk of Psychiatric Disorders following Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study.Soy Isoflavones Supplementation for Patients with Irritable Bowel Syndrome: A Randomized Double Blind Clinical Trial.Irritable bowel syndrome: a multidimensional disorder cannot be understood or treated from a unidimensional perspective Burden of constipation-predominant irritable bowel syndrome (IBS-C) in France, Italy, and the United Kingdom.A Novel Delivery System of Peppermint Oil Is an Effective Therapy for Irritable Bowel Syndrome Symptoms.How individuals with the irritable bowel syndrome describe their own symptoms before formal diagnosis.Which psychological factors exacerbate irritable bowel syndrome? Development of a comprehensive model.Mental Strain and Chronic Stress among University Students with Symptoms of Irritable Bowel Syndrome.Fear of GI symptoms has an important impact on quality of life in patients with moderate-to-severe IBS.Gluten-induced symptoms in diarrhea-predominant irritable bowel syndrome are associated with increased myosin light chain kinase activity and claudin-15 expression.High risk of temporomandibular disorder in irritable bowel syndrome: Is there a correlation with greater illness severity?Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice.Development and pilot testing of an integrated, web-based self-management program for irritable bowel syndrome (IBS).Predictive factors for compliance with transanal irrigation for the treatment of defecation disorders.Chronic prenatal stress epigenetically modifies spinal cord BDNF expression to induce sex-specific visceral hypersensitivity in offspring.Meditation over medication for irritable bowel syndrome? On exercise and alternative treatments for irritable bowel syndrome.Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis.Pros and Cons While Looking Through an Asian Window on the Rome IV Criteria for Irritable Bowel Syndrome: Pros.Altered gastrointestinal microbiota in irritable bowel syndrome and its modification by diet: probiotics, prebiotics and the low FODMAP diet.Psychological factors selectively upregulate rectal pain perception in hypersensitive patients with irritable bowel syndrome.Mapping of Brain Activations to Rectal Balloon Distension Stimuli in Male Patients with Irritable Bowel Syndrome Using Functional Magnetic Resonance Imaging.Assessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome - IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial.

P2860

Q26745706-E17F163B-DCCE-4E6C-A135-6914356284C4 Q26748617-0633EB4D-30CB-4196-8166-BFAAA38F281D Q30611547-1FA2F28F-57F4-4D72-8D44-AAB0A5AEC740 Q33668232-0C09646A-B7FA-4B35-92A4-EC39C0AC611A Q33696427-B2FCB0C0-99B4-411E-92CA-C86029F9F969 Q33828467-3F20C2B6-F20B-46DA-812F-9559AE63B2D2 Q33887153-4DE857CA-8682-4CBB-A6B4-7E930F1F30DD Q33925230-21B5BCCE-EA05-4F74-8B03-FCF3C520E837 Q33958801-A318C445-4CC6-40FC-BBB1-7FE00F5B3B94 Q34043062-5ABFADF6-18C2-4321-B37F-8EF0695C034F Q34129427-04FC33BD-992D-4EE2-A971-6A93B7B05A28 Q34168517-4997E613-2E06-4F30-B878-58B85828CCFC Q34493161-1217AA52-84C4-4DF0-8CDD-B0262ED5E96E Q34546729-C085FAB9-F241-4BAE-B100-7719D4A59EC3 Q34804619-5C0CB91C-4A12-4986-BEDD-2BD942F1BDFB Q34827497-3BE5A639-1969-4621-82A4-FC060A06F029 Q34887939-CBA36C93-E6C3-4A79-B7B3-358411BA2554 Q35552818-08697AC6-8F0F-44CB-9213-F46E7DE60142 Q35723382-14F64169-AB1D-42DB-B97D-2AA4D74B6487 Q36029571-6CFA593A-9F79-44CC-9F32-B6B4F917FB6A Q36379093-83D5F366-AB58-4993-8299-AD3D8FB6C01E Q36401806-1B3A0A06-8FDD-4EC2-AB2A-99482A813DDE Q36510964-C4ED2301-FFA6-41A6-8A98-585E1682D708 Q36754273-E6F0C19F-39B6-42D2-8AA6-FFB2E17E58D0 Q36904014-4BA0D9FE-B0B9-49A2-85B3-EB3258AF9611 Q36969663-D6B1C08B-D9C3-4C7B-9F04-65A5CBC6CC2B Q37415508-C9E004D5-7148-41E6-B4D3-661E456CAA95 Q37559869-A2A0ED07-4B74-41C1-8D3F-7567B1A45FB0 Q37572522-B8E0CE8B-0CF5-4FFD-B251-FABB681CD608 Q37632259-E245F85E-8F3F-42E7-88FC-4BDF0571291F Q37652847-1F094562-903C-4CDE-B9A8-D95A9D689F6D Q37714362-0149966A-3BBF-4C3A-A10C-4BEA416249D7 Q37719767-59F2C449-792A-4185-B5A4-D56E59822559 Q38015762-9EA42F4D-CAF1-40C4-98CE-EC42D56CBF65 Q38202523-6629C34E-004F-4688-AF0F-923EE21480DA Q38696423-A3018826-1993-4DF9-A920-FD82FAA5F748 Q38747496-26993421-2065-4A27-8943-9E39DA85AA30 Q38953372-4D9F618C-DB7C-4FDA-9093-85EE9F0D3DAD Q38963955-8DDD91A8-4296-403B-88A1-13E3BF8F47EE Q39152683-F5AE76E3-2EF3-48FE-BF77-5BA806606B0C

P2860

Severity in irritable bowel syndrome: a Rome Foundation Working Team report.

http://www.wikidata.org/entity/Q37900126

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 July 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Severity in irritable bowel syndrome: a Rome Foundation Working Team report.

@en

Severity in irritable bowel syndrome: a Rome Foundation Working Team report.

@nl

type

label

Severity in irritable bowel syndrome: a Rome Foundation Working Team report.

@en

Severity in irritable bowel syndrome: a Rome Foundation Working Team report.

@nl

prefLabel

Severity in irritable bowel syndrome: a Rome Foundation Working Team report.

@en

Severity in irritable bowel syndrome: a Rome Foundation Working Team report.

@nl

P1433

Q37900126-DADF1A85-6B21-4043-8BBD-13695D85501B

P1476

Q37900126-6B84FE8A-E996-4038-8D38-8A9B4C17F451

P2093

Q37900126-0FFB17A7-FB17-48CE-98DC-4142FFBD0616

Q37900126-1EA9BF43-3C59-441F-B526-365EFDFFCB63

Q37900126-3EC05FAF-EC33-4855-BEA2-FB2674F0E6DC

Q37900126-7707F5AC-927E-496C-A051-6C302702A8F1

Q37900126-84D6DA3A-74DE-4AFC-9DCD-1CAA866F2F9C

Q37900126-BAD3A10B-5FFC-413F-A177-B06E32FA60F3

Q37900126-D8F32BAE-F48D-4C47-9814-F6B13D7F8E10

P2860

Q37900126-11D5412E-09BE-4E0A-9750-312635FD726B

Q37900126-1942509A-2A0F-4A99-B237-63B82ECCE46D

Q37900126-217E61A0-0BEA-4091-A759-4D296B67684D

Q37900126-3BDB0722-E463-441C-9C5D-175F514298CF

Q37900126-550422C1-3006-4F90-AF50-6ABE5FBDA98F

Q37900126-5B8DDB7D-BAA7-4465-B707-58D0CC07F6CC

Q37900126-6A1D41E0-B9F5-45AE-BA6F-F747D41701B1

Q37900126-6C3A30CF-52A1-4FC0-A6E2-2EF30F8BAF6F

Q37900126-6E53E02A-46C7-41D7-ADDE-82F5E9460526

Q37900126-6F444A6F-5229-4006-85FD-C01583930CA5

P2888

Q37900126-FB7F91C6-EAF2-4E1A-9D1C-A4CBE7854489

P304

Q37900126-E6FD44D2-2CC0-4358-BABE-B9D25570DFAA

P31

Q37900126-E0F54A81-DFF6-4575-B43B-18FF99FE1EB6

P356

Q37900126-3DEB1B58-A2A7-4AFE-BAD9-5C98D0C3CDB5

P407

Q37900126-7E4D7747-B960-4EA2-A5B3-5FEDB71AC2B9

P433

Q37900126-D3504DFC-B6E4-4B05-AFB4-37935BA1799D

P478

Q37900126-CD58D727-5542-43DE-8F1C-D58DA6812A13

P50

Q37900126-EC40F7C1-9B4A-4E95-BE2B-EAB5C0B31540

P577

Q37900126-0CA97A7D-4743-40D9-89E9-596043E8BD29

P5875

Q37900126-3E1ADB38-27E5-4E09-97CA-21F5FCD554BB

P6179

Q37900126-3C9D06F2-1D6B-469D-88D0-BD73CBCEE9B5

P698

Q37900126-07DB6A12-216A-42D1-B3E5-BC56973352B3

P356

P1433

The American Journal of Gastroenterology

P1476

Severity in irritable bowel syndrome: a Rome Foundation Working Team report.

@en

P2093

A Lembo

http://www.w3.org/2001/XMLSchema#string

Douglas A Drossman

http://www.w3.org/2001/XMLSchema#string

F Mearin

http://www.w3.org/2001/XMLSchema#string

H E Gallo-Torres

http://www.w3.org/2001/XMLSchema#string

L Chang

http://www.w3.org/2001/XMLSchema#string

N Bellamy

http://www.w3.org/2001/XMLSchema#string

N J Norton

http://www.w3.org/2001/XMLSchema#string

P2860

A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome

Health-related quality of life in parents of school-age children with Asperger Syndrome or High-Functioning Autism

Enteric-coated peppermint-oil capsules in the treatment of irritable bowel syndrome: a prospective, randomized trial.

Predictors of patient-assessed illness severity in irritable bowel syndrome.

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders.

U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact.

AGA technical review on irritable bowel syndrome.

Do patients with irritable bowel syndrome in primary care really differ from outpatients with irritable bowel syndrome?

Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity.

The irritable bowel syndrome: review and a graduated multicomponent treatment approach.

P2888

P304

1749-59; quiz 1760

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/AJG.2011.201

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

Peter J Whorwell

P577

2011-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51484026

http://www.w3.org/2001/XMLSchema#string

P6179

1010584439

http://www.w3.org/2001/XMLSchema#string

P698

21747417

http://www.w3.org/2001/XMLSchema#string